A Comparative Study of Laparoscopic versus Open Pancreaticoduodenectomy for Ampulla of Vater Carcinoma.
Daegwang YooKi-Byung SongJong Woo LeeKyungyeon HwangSarang HongDakyum ShinDae Wook HwangJae Hoon LeeWoo Hyung LeeJae Woo KwonYe Jong ParkEunsung JunSong Cheol KimPublished in: Journal of clinical medicine (2020)
Several studies have compared laparoscopic pancreaticoduodenectomy (LPD) and open pancreaticoduodenectomy (OPD) in patients with periampullary carcinoma; however, only a few studies have made such a comparison on patients with ampulla of Vater cancer (AVC). We compared the perioperative and oncologic outcomes between LPD and OPD in patients with AVC using propensity-score-matched analysis. A total of 359 patients underwent PD due to AVC during the study period (76 LPD, 283 OPD). After propensity score matching, the LPD group showed significantly longer operation time than did the OPD group (400.2 vs. 344.6 min, p < 0.001). Nevertheless, the LPD group had fewer painkiller administrations (8.3 vs. 11.1, p < 0.049), fewer Grade II or more severe postoperative complications (15.9% vs. 34.8%, p = 0.012), and shorter postoperative hospital stays (13.7 vs. 17.3 days, p = 0.048), compared with the OPD group. There was no significant difference in recurrence-free outcomes and overall survival between the two groups (p = 0.754 and 0.768, respectively). Compared with OPD, LPD for AVC had comparative oncologic outcomes with less pain, less postoperative morbidity, and shorter hospital stays. LPD may serve as a promising alternative to OPD in patients with AVC.
Keyphrases
- robot assisted
- patients undergoing
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- chronic pain
- chronic kidney disease
- peritoneal dialysis
- cardiac surgery
- prognostic factors
- prostate cancer
- radical prostatectomy
- early onset
- pain management
- squamous cell carcinoma
- emergency department
- acute kidney injury
- free survival
- acute care
- adipose tissue
- metabolic syndrome
- neuropathic pain
- squamous cell
- young adults
- glycemic control